1. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy
   L Hu et al, 2017, Oncogene CrossRef
2. Ubiquitin-conjugating enzyme E2T promotes tumor stem cell characteristics and migration of cervical cancer cells by regulating the GRP78/FAK pathway
   YanMei Liu et al, 2021, Open Life Sciences CrossRef
3. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid Cancer
   Wenjun Xie et al, 2024, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
4. Autoinhibition Mechanism of the Ubiquitin-Conjugating Enzyme UBE2S by Autoubiquitination
   Anna K.L. Liess et al, 2019, Structure CrossRef
5. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells
   Jhih-Yun Ho et al, 2021, Cellular Oncology CrossRef
6. Natural Compounds Derived from Plants on Prevention and Treatment of Renal Cell Carcinoma: A Literature Review
   Zhenjie Yin et al, 2023, Advanced Biology CrossRef
7. Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma
   Ommoleila Molavi et al, 2015, Leukemia & Lymphoma CrossRef
8. Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling
   Anmol Sharma et al, 2021, International Journal of Molecular Sciences CrossRef
9. Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn/GDNF and MAPK signaling pathway
   Manar Mohammed El Tabaa et al, 2022, Inflammopharmacology CrossRef
10. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness
    Kaijie Wu et al, 2013, Cellular Signalling CrossRef
11. Dietary flavonoids, luteolin and quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial–mesenchymal transition signaling
    Tsung-Han Lin et al, 2017, Food & Function CrossRef
12. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system
    Shusaku Yoshimura et al, 2017, Biochemical and Biophysical Research Communications CrossRef
13. WITHDRAWN: Production of a novel UBE2S anti-body and significance of its expression in some tumors
    Xiaohui Zhang et al, 2014, Pathology - Research and Practice CrossRef
14. UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
    Zhi Liu et al, 2018, BMB Reports CrossRef
15. Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
    Li Hu et al, 2021, Frontiers in Oncology CrossRef
16. Research Progress of UBE2S in Digestive Sys-tem Tumors
    湾 李, 2023, Advances in Clinical Medicine CrossRef
17. UBE2S is associated with malignant characteristics of breast cancer cells
    Akter Khondker Ayesha et al, 2016, Tumor Biology CrossRef
18. Diverse roles of UBE2S in cancer and therapy resistance: Biological functions and mechanisms
    Mengjun Zhang et al, 2024, Heliyon CrossRef
19. Epidermal growth factors in the kidney and relationship to hypertension
    Alexander Staruschenko et al, 2013, American Journal of Physiology-Renal Physiology CrossRef
20. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients
    Xiaolin Lu et al, 2016, Tumor Biology CrossRef
21. Ectopic High Expression of E2-EPF Ubiquitin Carrier Protein Indicates a More Unfavorable Prognosis in Brain Glioma
    Xiaohui Zhang et al, 2017, Genetic Testing and Molecular Biomarkers CrossRef
22. Free-fatty acid receptor-1 (FFA1/GPR40) promotes papillary RCC proliferation and tumor growth via Src/PI3K/AKT/NF-κB but suppresses migration by inhibition of EGFR, ERK1/2, STAT3 and EMT
    Priyanka F. Karmokar et al, 2023, Cancer Cell International CrossRef